Evidence map›Paper›PMID 29748753›Full record

ArticleJournal of materials science. Materials in medicine2018

Electrospun poly(ε-caprolactone) matrices containing silver sulfadiazine complexed with β-cyclodextrin as a new pharmaceutical dosage form to wound healing: preliminary physicochemical and biological evaluation.

Sarah Oliveira Lamas Souza, Monique Alvarenga Pinto Cotrim, Rodrigo Lambert Oréfice, Suzana Gonçalves Carvalho, Jessyca Aparecida Paes Dutra, Francisco de Paula Careta, Juliana Alves Resende, Janaina Cecília Oliveira Villanova

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sarah Oliveira Lamas SouzaDepartamento de Engenharia Metalúrgica e de Materiais, Universidade Federal de Minas Gerais - UFMG, Av. Antônio Carlos, 6627, Bloco 2, Pampulha, 31.270-900, Belo Horizonte, MG, Brazil.
Monique Alvarenga Pinto CotrimDepartamento de Engenharia Metalúrgica e de Materiais, Universidade Federal de Minas Gerais - UFMG, Av. Antônio Carlos, 6627, Bloco 2, Pampulha, 31.270-900, Belo Horizonte, MG, Brazil.
Rodrigo Lambert OréficeDepartamento de Engenharia Metalúrgica e de Materiais, Universidade Federal de Minas Gerais - UFMG, Av. Antônio Carlos, 6627, Bloco 2, Pampulha, 31.270-900, Belo Horizonte, MG, Brazil.
Suzana Gonçalves CarvalhoUniversidade Federal do Espírito Santo - UFES, Departamento de Farmácia e Nutrição, Centro de Ciências Exatas, Naturais e de Saúde, Av. Alto Universitário, sem número, Guararema, Alegre, ES, 29.500-000, Brazil.
Jessyca Aparecida Paes DutraDepartamento de Farmácia, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo - UFES, Av. Marechal Campos, 1468, Vitória, ES, 29.043-900, Brazil.
Francisco de Paula CaretaUniversidade Federal do Espírito Santo - UFES, Departamento de Farmácia e Nutrição, Centro de Ciências Exatas, Naturais e de Saúde, Av. Alto Universitário, sem número, Guararema, Alegre, ES, 29.500-000, Brazil.
Juliana Alves ResendeUniversidade Federal do Espírito Santo - UFES, Departamento de Farmácia e Nutrição, Centro de Ciências Exatas, Naturais e de Saúde, Av. Alto Universitário, sem número, Guararema, Alegre, ES, 29.500-000, Brazil.
Janaina Cecília Oliveira VillanovaUniversidade Federal do Espírito Santo - UFES, Departamento de Farmácia e Nutrição, Centro de Ciências Exatas, Naturais e de Saúde, Av. Alto Universitário, sem número, Guararema, Alegre, ES, 29.500-000, Brazil. pharmacotecnica@yahoo.com.br.ORCID http://orcid.org/0000-0001-6166-1724

Funding

Fundação de Amparo à Pesquisa e Inovação do Espírito Santo 552/2015
6 · The paper itself

Abstract

Cooperation between researchers in the areas of medical, pharmaceutical and materials science has facilitated the development of pharmaceutical dosage forms that elicit therapeutic effects and protective action with a single product. In addition to optimizing pharmacologic action, such dosage forms provide greater patient comfort and increase success and treatment compliance. In the present work, we prepared semipermeable bioactive electrospun fibers for use as wound dressings containing silver sulfadiazine complexed with β-cyclodextrin in a poly(Ɛ-caprolactone) nanofiber matrix aiming to reduce the direct contact between silver and skin and to modulate the drug release. Wound dressings were prepared by electrospinning, and were subjected to ATR-FT-IR and TG/DTG assays to evaluate drug stability. The hydrophilicity of the fibrous nanostructure in water and PBS buffer was studied by goniometry. Electrospun fibers permeability and swelling capacity were assessed, and a dissolution test was performed. In vitro biological tests were realized to investigate the biological compatibility and antimicrobial activity. We obtained flexible matrices that were each approximately 1.0 g in weight. The electrospun fibers were shown to be semipermeable, with water vapor transmission and swelling indexes compatible with the proposed objective. The hydrophilicity was moderate. Matrices containing pure drug modulated drug release adequately during 24 h but presented a high hemolytic index. Complexation promoted a decrease in the hemolytic index and in the drug release but did not negatively impact antimicrobial activity. The drug was released predominantly by diffusion. These results indicate that electrospun PCL matrices containing β-cyclodextrin/silver sulfadiazine inclusion complexes are a promising pharmaceutical dosage form for wound healing.

Indexed as

Wound HealingBandagesbeta-CyclodextrinsBlood CellsChemical PhenomenaDosage FormsDrug CarriersDrug LiberationDrug StabilityElectroplatingHemolysisHumansMaterials TestingMicrobial Sensitivity TestsNanofibersPolyestersbeta-CyclodextrinsDosage FormsDrug CarrierspolycaprolactonePolyestersSilver Sulfadiazine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.